NTN1
Chr 17ADnetrin 1
Also known as: MRMV4, NET1, NTN1L
Netrin-1 is a secreted guidance protein that controls axon pathfinding during development by attracting or repelling growing axons depending on which receptors it binds. Mutations cause autosomal dominant mirror movements, a condition where voluntary movements on one side of the body are involuntarily mirrored on the opposite side due to abnormal crossing of motor pathways in the brainstem. The gene is highly constrained against loss-of-function variants (pLI 0.997, LOEUF 0.222), indicating that most protein-truncating variants are likely pathogenic.
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly LoF-intolerant (top ~10% of genes)
Moderately missense-constrained (top ~2.5%)
The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).
Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.
ClinVar Variant Classifications
140 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 0 | 3 | 10 | 0 | 13 |
Likely Pathogenic | 0 | 0 | 0 | 0 | 0 |
VUS | 2 | 85 | 4 | 0 | 91 |
Likely Benign | 0 | 3 | 3 | 13 | 19 |
Benign | 0 | 0 | 1 | 5 | 6 |
| Total | 2 | 91 | 18 | 18 | 129 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
NTN1 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
3D Protein StructureAlphaFold
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
NOT YET RECRUITINGNP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies
ACTIVE NOT RECRUITINGExternal Resources
Links to major genomics databases and tools